How to manage hyperglycemia in a patient taking Lantus (insulin glargine) and Metformin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyperglycemia with Blood Sugar of 360 mg/dL

For a patient with a blood sugar of 360 mg/dL who is currently on Lantus (insulin glargine) and metformin, immediate intensification of insulin therapy is required by adding rapid-acting insulin before meals while adjusting the basal insulin dose.

Immediate Management

  • For severe hyperglycemia (>300 mg/dL), rapid-acting insulin should be administered immediately to lower blood glucose levels 1
  • A starting dose of 6 units of rapid-acting insulin analog (insulin aspart, lispro, or glulisine) should be given subcutaneously to address the current hyperglycemia 1
  • Check blood glucose 3 hours after administration to assess response 1
  • Assess for ketosis - if moderate to severe ketosis is present (ketonuria 2+ or ketonemia ≥1.5 mmol/L), consider transfer to higher level of care for IV insulin therapy 1

Short-Term Treatment Plan

  • Increase the current Lantus (insulin glargine) dose systematically to 0.1-0.2 units/kg/day if not already at this level 2
  • Add prandial (mealtime) insulin therapy with rapid-acting insulin analogs before meals 1
  • Initial prandial insulin dosing should be approximately 4 units before each meal, or calculated as 50% of total daily insulin divided among three meals 2
  • Continue metformin at the current dose as it complements insulin therapy by reducing insulin resistance 1
  • Titrate basal insulin (Lantus) by adding 2-4 units every 3 days until fasting blood glucose approaches target range of 100-120 mg/dL 2

Insulin Adjustment Algorithm

  • Adjust basal insulin (Lantus) by adding 1-2 units (or 5-10% for higher doses) once or twice weekly if fasting glucose remains above target 1
  • Adjust prandial insulin based on pre-meal and 2-hour post-meal glucose readings 1
  • Target pre-meal glucose of 80-130 mg/dL and post-meal glucose <180 mg/dL 1
  • Monitor for hypoglycemia, especially during the initial titration phase 2, 3

Patient Education

  • Provide comprehensive education on proper insulin injection technique, timing, and storage 1
  • Teach blood glucose monitoring schedule: before meals, at bedtime, and occasionally 2 hours after meals 1
  • Educate about hypoglycemia recognition, prevention, and treatment 1, 2
  • Review "sick day" management rules to prevent severe hyperglycemia during illness 1

Important Considerations

  • If the patient has catabolic features (weight loss, ketosis) or very high HbA1c (≥10%), a more aggressive insulin regimen is warranted 1
  • Once glycemic control is achieved, it may be possible to reduce insulin doses, but this should be done gradually 1
  • Drug interactions: monitor for increased hypoglycemia risk when insulin is used with ACE inhibitors, fibrates, salicylates, or other medications that enhance insulin sensitivity 3
  • Avoid alcohol consumption as it potentiates the effect of metformin on lactate metabolism and increases hypoglycemia risk 4

Common Pitfalls to Avoid

  • Failing to intensify insulin therapy promptly when blood glucose is severely elevated 1, 2
  • Inadequate patient education about insulin administration and glucose monitoring 1, 2
  • Insufficient insulin dose adjustments - systematic titration is necessary 1, 2
  • Neglecting to check for ketosis in the setting of severe hyperglycemia 1
  • Continuing to increase insulin without addressing potential insulin resistance factors 5

By following this approach, the patient's severe hyperglycemia can be addressed immediately while establishing a sustainable insulin regimen for long-term glycemic control.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Uncontrolled Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can a 61-year-old male with type 2 diabetes, currently on metformin (biguanide) 500 mg twice a day, glipizide (sulfonylurea) 2.5 mg, and Lantus (insulin glargine) 6 units, safely omit Lantus from his regimen?
What is the next step in managing a patient with type 2 diabetes already on metformin (Metformin), Actos (Pioglitazone), Glizipide (Glipizide), and Lantus (Insulin Glargine)?
What is the suitable initial insulin dose for a 60kg female patient with severe hyperglycemia?
What is the recommended increase in insulin dose for a patient with HbA1c of 9% on Lantus (insulin glargine) 40 units, Novolog (insulin aspart) 9 units TID, Farxiga (dapagliflozin), and Metformin (metformin)?
Should a patient with poor glycemic control on metformin 500 mg daily increase metformin to 500 mg twice daily, start Lantus (insulin glargine), and sliding scale insulin?
What are the management considerations for a patient taking etodolac (LODINE) XL 600 MG 24 hr tablet?
What are the recommended medications for treating restless leg syndrome?
What non-narcotic options are available for managing lumbosacral sciatica pain due to a herniated disc when anti-inflammatory medications and acetaminophen are ineffective but Tramacet (tramadol and acetaminophen) shows some efficacy?
What is the best management approach for a patient with hypertension, hypercholesterolemia, impaired renal function, and hypoglycemia?
Are clotrimazole (antifungal medication) troches safe to use during pregnancy?
What is the recommended treatment for oral thrush in the 3rd trimester of pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.